These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
5. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913 [TBL] [Abstract][Full Text] [Related]
6. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Mathur RS; Landgrebe SC; Moody LO; Semmens JP; Williamson HO Maturitas; 1985 Jul; 7(2):129-33. PubMed ID: 3929023 [TBL] [Abstract][Full Text] [Related]
7. Steroid and gonadotropin profiles in menopausal women on three different oral replacement regimens. Sipinen S; Lähteenmäki P Ann Clin Res; 1980 Dec; 12(6):282-7. PubMed ID: 6786204 [TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Rose DP; Davis TE Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282 [TBL] [Abstract][Full Text] [Related]
9. Effects of chronic alcoholism on the pituitary-gonadal function of women during menopausal transition and in the post menopausal period. Hugues JN; Perret G; Adessi G; Coste T; Modigliani E Biomedicine; 1978 Nov; 29(8):279-83. PubMed ID: 369630 [TBL] [Abstract][Full Text] [Related]
10. Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein. Helgason S; Damber MG; von Schoultz B; Stigbrand T Acta Obstet Gynecol Scand; 1982; 61(1):75-9. PubMed ID: 6283781 [TBL] [Abstract][Full Text] [Related]
12. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women]. Araya V; Contreras P; Aguirre C; Foradori A Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735 [TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times. Clemente C; Russo F; Caruso MG; Giangrande M; Fanizza G; Di Leo A Horm Metab Res; 1992 Apr; 24(4):191-3. PubMed ID: 1318259 [TBL] [Abstract][Full Text] [Related]
15. Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals. Mueller A; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Dittrich R Horm Metab Res; 2006 Mar; 38(3):183-7. PubMed ID: 16673210 [TBL] [Abstract][Full Text] [Related]
16. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women. Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of prolactin secretion by estrogen in hypogonadal women. Yen SS; Ehara Y; Siler TM J Clin Invest; 1974 Feb; 53(2):652-5. PubMed ID: 11344580 [TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer. Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557 [TBL] [Abstract][Full Text] [Related]
19. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]